Comparison
5p Partial Monosomy Syndrome C0010314 vs 3 Beta Hydroxysteroid Dehydrogenase Deficiency C0342471
Clinical comparison between 5P Partial Monosomy Syndrome and 3 Beta Hydroxysteroid Dehydrogenase Deficiency for differential diagnosis and treatment planning.
5p Partial Monosomy Syndrome C0010314
Also called Cri-du-chat syndrome, caused by a deletion on chromosome 5. Features include a high-pitched cry, developmental delay, and intellectual disability.
3 Beta Hydroxysteroid Dehydrogenase Deficiency C0342471
A rare genetic disorder affecting adrenal hormone production. It can cause ambiguous genitalia, salt-wasting crises, and hormonal imbalances. Treatment requires hormone replacement therapy and careful monitoring.
6 comparison axes
Onset
5p Partial Monosomy Syndrome C0010314
0-0
3 Beta Hydroxysteroid Dehydrogenase Deficiency C0342471
0-null
Onset patterns differ
Severity
5p Partial Monosomy Syndrome C0010314
severe
3 Beta Hydroxysteroid Dehydrogenase Deficiency C0342471
severe
Different severity levels
Chronic
5p Partial Monosomy Syndrome C0010314
Chronic
3 Beta Hydroxysteroid Dehydrogenase Deficiency C0342471
Chronic
Differing course
Communicable
5p Partial Monosomy Syndrome C0010314
No
3 Beta Hydroxysteroid Dehydrogenase Deficiency C0342471
No
Different transmission
Body System
5p Partial Monosomy Syndrome C0010314
congenital
3 Beta Hydroxysteroid Dehydrogenase Deficiency C0342471
endocrine
Same/different system
Category
5p Partial Monosomy Syndrome C0010314
genetic
3 Beta Hydroxysteroid Dehydrogenase Deficiency C0342471
endocrine
Different category
Bottom line
5p-partial-monosomy-syndrome-C0010314 and 3-beta-hydroxysteroid-dehydrogenase-deficiency-C0342471 differ in etiology
Key differentiating points
Findings that most reliably separate the two conditions at the bedside or in the workup.
| Feature | 5p Partial Monosomy Syndrome C0010314 | 3 Beta Hydroxysteroid Dehydrogenase Deficiency C0342471 | Discriminating power |
|---|---|---|---|
| Neonatal cry and development | High-pitched cat-like cry with developmental delay and intellectual disability may occur. | Cry and cognition are not defining features; adrenal crisis or genital ambiguity may dominate. | High |
| Genital and salt-balance findings | Not primarily an adrenal or genital-development disorder. | Ambiguous genitalia, salt wasting, and hormonal imbalance may occur. | High |
| Growth and facial features | Congenital dysmorphic and growth features may be present; exact pattern varies. | Features reflect steroid deficiency rather than a chromosome 5 deletion. | Moderate |
When to favor each condition
Choose 5p Partial Monosomy Syndrome C0010314 when
Characteristic cry plus developmental concerns
This pattern supports chromosomal evaluation for 5p deletion rather than adrenal testing alone.
High
Dysmorphic features without adrenal crisis
A congenital chromosomal condition is more consistent than steroid-enzyme deficiency.
Moderate
Known chromosome 5 deletion
Genetic confirmation distinguishes the syndrome from an endocrine enzyme disorder.
High
Choose 3 Beta Hydroxysteroid Dehydrogenase Deficiency C0342471 when
Salt-wasting or adrenal crisis
Acute electrolyte and adrenal findings point toward disordered steroid production.
High
Ambiguous genitalia with hormonal imbalance
This pattern fits a disorder of sex-steroid and adrenal synthesis.
High
Abnormal steroid profile needing confirmation
Specialist endocrine and genetic assessment is needed; a result alone is not definitive.
Moderate
How key tests differ
| Test | 5p Partial Monosomy Syndrome C0010314 | 3 Beta Hydroxysteroid Dehydrogenase Deficiency C0342471 | Interpretation |
|---|---|---|---|
| Chromosomal microarray or karyotype | May show deletion involving chromosome 5p. | Does not establish this enzyme deficiency. | A chromosomal result supports the left condition but requires laboratory confirmation. |
| Steroid hormone profile | No characteristic adrenal steroid pattern is established. | May show disordered adrenal and sex-steroid production. | Interpret with age, sex, and clinical context; no cutoff is supplied here. |
| Electrolytes during illness | No specific salt-wasting pattern is defining. | May reveal salt wasting during crisis. | Abnormal electrolytes suggest urgency but do not alone diagnose either condition. |
Prognosis comparison
5p Partial Monosomy Syndrome C0010314
- Outcome
- Often lifelong neurodevelopmental disability; survival and function vary.
- Factors
- Deletion extent, associated anomalies, and support services may influence outcome.
3 Beta Hydroxysteroid Dehydrogenase Deficiency C0342471
- Outcome
- Can be severe, especially with salt-wasting, but outcome depends on recognition and treatment.
- Factors
- Crisis prevention, hormone management, and monitoring are important; exact outcomes are not established here.
Time frame: Both are generally chronic and may present in infancy.
Prognosis should be individualized; comparative mortality is not established by these sources.
Complications comparison
| Complication | Presentation |
|---|---|
| Developmental disability | Intellectual disability and developmental delay are central reported features. Not the primary described complication. Support needs vary and should be individualized. |
| Adrenal crisis | Not a characteristic complication from the supplied description. Salt-wasting crisis may be life-threatening. Urgent clinician care is needed for suspected crisis. |
| Hormonal imbalance | Not the main disease mechanism. Chronic imbalance may require replacement and monitoring. Doses and targets must be set by specialists. |
Patient education highlights
- HighDifferent causes
One condition involves missing chromosome 5 material; the other affects adrenal hormone production.
- HighUrgent warning signs
Poor feeding, vomiting, dehydration, or collapse need urgent assessment, especially if adrenal disease is possible.
- MediumLong-term care
Both may need lifelong specialist follow-up, developmental support, or hormone monitoring as clinically indicated.